
Sunshine Biopharma is a drug manufacturers - specialty & generic company in the healthcare sector on NASDAQ, led by Dr. Steve N. Slilaty, with a market cap of $6.8M.
Overview of institutional ownership in SBFM as of Q3 2025 with a market cap of $6.8M
Based on market cap of $6.8M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in SBFM as of Q3 2025
| Institution | Position Value |
|---|---|
S SABBY MANAGEMENT, LLC Institution | - 0.00% of portfolio |
Institutional buying and selling activity for SBFM in Q3 2025
| Institution | Net Bought | |
|---|---|---|
| No buyers found | ||
| Institution | Net Sold | |
|---|---|---|
| No sellers found | ||
Institutions that initiated new positions or completely exited SBFM in Q3 2025
| Institution | Position Value |
|---|---|
| No new positions found | |
| Institution | Previous Position |
|---|---|
S SABBY MANAGEMENT, LLC Institution | $2.2K 1.6K shares |
Institutions with the largest Call and Put options positions in SBFM as of Q3 2025
| Institution | Position Value |
|---|---|
| No call positions found | |
| Institution | Position Value |
|---|---|
| No put positions found | |
Institutions with SBFM as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
S SABBY MANAGEMENT, LLC Institution | 0.00% - |
We use cookies for analytics. See our Privacy and Cookie Policy.